Biocon QIP: Pharma company to raise Rs 4,500 cr; check floor price

n has initiated its Qualified Institutional Placement on January 12, 2026, after receiving approvals from its board and shareholders last month. The Fundraising Committee, at its meeting held on Monday, authorised the opening of the issue, approved the floor price at Rs 387.74 per equity share in line with SEBI’s pricing norms, and cleared the preliminary placement document. "We wish to inform you that the Fund Raising Committee has fixed the ‘relevant date’ for the purpose of the Issue, in terms of Regulation 171 of the SEBI ICDR Regulations, as January 12, 2026, and accordingly the Floor Price in respect of the Issue has been determined, based on the pricing formula as prescribed under Regulation 176(1) of the SEBI ICDR Regulations, as Rs 387.74 per Equity Share," the company said in an exchange filing.